HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.

Abstract
Fewer people infected with human immunodeficiency virus (HIV) type 2 progress to acquired immunodeficiency syndrome, compared with those infected with HIV-1. To understand the immune mechanisms leading to slow progression in HIV-2 infection, cell-mediated immune responses were compared between the 2 infections in asymptomatic subjects with a CD4 cell count > or =20%. Interferon- gamma release from T lymphocytes and the cytotoxicity of CD8+ T lymphocytes were measured by ELISPOT and 51Cr release assays. The level of responses and the proportion of responders were similar in the 2 infections, despite a 20-fold difference in their geometric mean plasma virus loads. The proliferation of CD4+ T helper cells, which was evaluated by thymidine incorporation, was not different between the 2 infections. Contrary to widely held views, our results suggest that nonprogression in HIV-2 infection may not be due to more vigorous immune responses.
AuthorsAssan Jaye, Ramu Sarge-Njie, Maarten Schim van der Loeff, Jim Todd, Abraham Alabi, Shehu Sabally, Tumani Corrah, Hilton Whittle
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 189 Issue 3 Pg. 498-505 (Feb 01 2004) ISSN: 0022-1899 [Print] United States
PMID14745708 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interferon-gamma
Topics
  • Adult
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cytotoxicity, Immunologic
  • Female
  • Gambia
  • HIV Infections (blood, immunology, virology)
  • HIV-1 (immunology)
  • HIV-2 (immunology)
  • Humans
  • Immunity, Cellular
  • Interferon-gamma (analysis)
  • Male
  • T-Lymphocytes (immunology)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: